rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    AYTU
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Why is Aytu BioPharma stock surging today?
      Nov 17Investing.comAYTU
      12 Health Care Stocks Moving In Tuesday's Pre-Market Session
      Nov 17BenzingaAYTU
      Why Aytu Biopharma Shares Are Trading Higher By 43%; Here Are 20 Stocks Moving Premarket
      Nov 17BenzingaAYTUAEON
      Aytu BioPharma earnings beat by $0.14, revenue topped estimates
      Nov 16Investing.comAYTU
      Aytu BioPharma, Inc. (AYTU) Reports Q1 Loss, Beats Revenue Estimates
      Nov 16Yahoo FinanceAYTU
      Aytu BioPharma Reports Fiscal 2027 First Quarter Operational and Financial Results
      Nov 16Yahoo FinanceAYTU
      Aytu BioPharma to Report Fiscal 2027 First Quarter Operational and Financial Results on November 16, 2026
      Nov 10Yahoo FinanceAYTU
      Aytu BioPharma at lytham partners fall 2026: exxua drives shift
      Sep 29Investing.comAYTU
      Aytu BioPharma, Inc. Q4 2026 Earnings Call Summary

      Moby summary of Aytu BioPharma, Inc.'s Q4 2026 earnings call

      Sep 23Yahoo FinanceAYTU
      Aytu BioPharma Inc (AYTU) (Q4 2026) Earnings Call Highlights: EXXUA Launch Accelerates as ...

      Aytu BioPharma Inc (AYTU) posted $16.1 million in Q4 FY2026 revenue as EXXUA prescriptions surged 138% and the company swung to positive adjusted EBITDA of $0.5 million.

      Sep 23Yahoo FinanceAYTU
      Earnings call transcript: Aytu BioPharma tops Q4 2026 revenue forecast
      Sep 22Investing.comAYTU
      Transcript: Aytu BioPharma Q4 2026 Earnings Conference Call - Aytu BioPharma (NASDAQ:AYTU)

      On Tuesday, Aytu BioPharma (NASDAQ:AYTU) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time

      Sep 22BenzingaAYTU
      Aytu BioPharma, Inc. (AYTU) Reports Q4 Loss, Beats Revenue Estimates
      Sep 22Yahoo FinanceAYTU
      Aytu BioPharma beats Q4 estimates on EXXUA launch momentum, shares rise 4%
      Sep 22Investing.comAYTU
      Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results
      Sep 22Yahoo FinanceAYTU
      Aytu BioPharma to Report Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results on September 22, 2026

      DENVER, CO / ACCESS Newswire / September 16, 2026 / (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will report its operational and financial results for its fiscal 2026 full year and fourth quarter, after the market close on Tuesday, September 22, 2026. The Company has scheduled a conference call and webcast that same day, Tuesday, September 22, 20

      Sep 16Yahoo FinanceAYTU

      This is the newest page. Registered accounts read further back.